First documented case of human babesiosis in Sweden

Scand J Infect Dis. 1992;24(4):541-7. doi: 10.3109/00365549209052642.

Abstract

A 34-year-old splenectomized man presented with fever, myalgia and dysuria. His condition rapidly deteriorated, he became anuric and developed severe haemolytic anaemia, thrombocytopenia and fibrinolysis. Peripheral blood smears revealed intra-erythrocytic parasites consistent with Babesia divergens in 40% of the erythrocytes. The diagnosis was confirmed by gerbil inoculation and by a significant rise in antibody titer. Blood exchange transfusion reduced the number of babesia infected erythrocytes to 1%. Parenteral therapy with a combination of quinine and clindamycin eradicated parasitaemia after 10 days of treatment and the patient rapidly improved. Renal failure necessitated haemodialysis for one month, whereafter the patient made a full recovery. Human babesiosis is a rare disease, but with a potential fatal outcome and should be considered as a diagnostic alternative in splenectomized and otherwise immunocompromised individuals with severe febrile illnesses.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Animals
  • Antibodies, Protozoan / blood
  • Babesia / immunology
  • Babesia / isolation & purification
  • Babesiosis / complications
  • Babesiosis / diagnosis*
  • Babesiosis / therapy
  • Clindamycin / administration & dosage
  • Combined Modality Therapy
  • Drug Therapy, Combination / administration & dosage
  • Erythrocytes / parasitology
  • Exchange Transfusion, Whole Blood
  • Humans
  • Male
  • Quinine / administration & dosage
  • Renal Dialysis
  • Splenectomy
  • Sweden
  • Uremia / etiology
  • Uremia / therapy

Substances

  • Antibodies, Protozoan
  • Clindamycin
  • Quinine